These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

476 related articles for article (PubMed ID: 28228120)

  • 1. Findings of transoesophageal echocardiogram in appropriately anticoagulated patients with persistent atrial fibrillation prior to planned cardioversion.
    Barysienė J; Žebrauskaitė A; Petrikonytė D; Marinskis G; Aidietienė S; Aidietis A
    BMC Cardiovasc Disord; 2017 Feb; 17(1):67. PubMed ID: 28228120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NOACs and atrial fibrillation: Incidence and predictors of left atrial thrombus in the real world.
    Bertaglia E; Anselmino M; Zorzi A; Russo V; Toso E; Peruzza F; Rapacciuolo A; Migliore F; Gaita F; Cucchini U; De Divitiis M; Iliceto S; Stabile G
    Int J Cardiol; 2017 Dec; 249():179-183. PubMed ID: 29121724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel Oral Anticoagulants in Direct Current Cardioversion for Atrial Fibrillation.
    Femia G; Fetahovic T; Shetty P; Lee A
    Heart Lung Circ; 2018 Jul; 27(7):798-803. PubMed ID: 28802808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transesophageal echocardiography before cardioversion of recurrent atrial fibrillation: does absence of previous atrial thrombi preclude the need of a repeat test?
    Shen X; Li H; Rovang K; Hee T; Holmberg MJ; Mooss AN; Mohiuddin SM
    Am Heart J; 2003 Oct; 146(4):741-5. PubMed ID: 14564332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Left Ventricular Ejection Fraction Is Associated with the Risk of Thrombus in the Left Atrial Appendage in Patients with Atrial Fibrillation.
    Uziębło-Życzkowska B; Krzesiński P; Jurek A; Kapłon-Cieślicka A; Gorczyca I; Budnik M; Gielerak G; Kiliszek M; Gawałko M; Scisło P; Kochanowski J; Jelonek O; Michalska A; Starzyk K; Filipiak KJ; Wożakowska-Kapłon B; Opolski G
    Cardiovasc Ther; 2020; 2020():3501749. PubMed ID: 32411299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transoesophageal echocardiography-guided cardioversion of atrial fibrillation or flutter. Selection of a low-risk group for immediate cardioversion.
    Roijer A; Eskilsson J; Olsson B
    Eur Heart J; 2000 May; 21(10):837-47. PubMed ID: 10781356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Post-cardioversion transesophageal echocardiography (POSTEC) strategy with the use of enoxaparin for brief anticoagulation in atrial fibrillation patients: the multicenter POSTEC trial (a pilot study).
    Sorino M; Colonna P; De Luca L; Carerj S; Oliva E; De Tommasi SM; Conti U; Iacopi F; D'Agostino C; D'Amato N; Pettinati G; Montericcio V; Cualbu A; De Luca I
    J Cardiovasc Med (Hagerstown); 2007 Dec; 8(12):1034-42. PubMed ID: 18163016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transesophageal vs. intracardiac echocardiographic screening in patients undergoing atrial fibrillation ablation with uninterrupted rivaroxaban.
    Tsyganov A; Shapieva A; Sandrikov V; Fedulova S; Mironovich S; Dzeranova A; Lyan E
    BMC Cardiovasc Disord; 2017 Jun; 17(1):171. PubMed ID: 28662693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atrial fibrillation type and renal dysfunction as important predictors of left atrial thrombus.
    Kapłon-Cieślicka A; Budnik M; Gawałko M; Peller M; Gorczyca I; Michalska A; Babiarz A; Bodys A; Uliński R; Żochowski M; Scisło P; Kochanowski J; Filipiak KJ; Opolski G
    Heart; 2019 Sep; 105(17):1310-1315. PubMed ID: 31040170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is transesophageal echocardiography necessary before electrical cardioversion in patients treated with non-vitamin K antagonist oral anticoagulants? Current evidence and practical approach.
    Gorczyca I; Uziębło-Życzkowska B; Krzesiński P; Major A; Kapłon-Cieślicka A
    Cardiol J; 2023; 30(4):646-653. PubMed ID: 34671967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of left atrial appendage thrombus despite NOAC use in nonvalvular atrial fibrillation and flutter.
    Shah M; Mobaligh N; Niku A; Shiota T; Siegel RJ; Rader F
    Int J Cardiol; 2020 Oct; 317():86-90. PubMed ID: 32344001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Left atrial appendage thrombus in patients with atrial fibrillation who underwent oral anticoagulation.
    Karwowski J; Rekosz J; Mączyńska-Mazuruk R; Wiktorska A; Wrzosek K; Loska W; Szmarowska K; Solecki M; Sumińska-Syska J; Dłużniewski M
    Cardiol J; 2024; 31(3):461-471. PubMed ID: 35703043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of spontaneous echocontrast, 'sludge' and thrombi before cardioversion in patients with atrial fibrillation: new insights into the role of transesophageal echocardiography.
    Maltagliati A; Galli CA; Tamborini G; Celeste F; Muratori M; Pepi M
    J Cardiovasc Med (Hagerstown); 2009 Jul; 10(7):523-8. PubMed ID: 19474574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atrial thrombi resolution after prolonged anticoagulation in patients with atrial fibrillation.
    Corrado G; Tadeo G; Beretta S; Tagliagambe LM; Manzillo GF; Spata M; Santarone M
    Chest; 1999 Jan; 115(1):140-3. PubMed ID: 9925075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Left atrial thrombus in patients with atrial fibrillation and under oral anticoagulant therapy; 3-D transesophageal echocardiographic study.
    Durmaz E; Karpuz MH; Bilgehan K; Ikitimur B; Ozmen E; Ebren C; Polat F; Koca D; Tokdil KO; Kandemirli SG; Atici A; Ongen Z
    Int J Cardiovasc Imaging; 2020 Jun; 36(6):1097-1103. PubMed ID: 32140812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of transesophageal contrast echocardiography for excluding left atrial appendage thrombi in patients with atrial fibrillation before cardioversion.
    von der Recke G; Schmidt H; Illien S; Lüderitz B; Omran H
    J Am Soc Echocardiogr; 2002 Oct; 15(10 Pt 2):1256-61. PubMed ID: 12411914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of transoesophageal echocardiography before cardioversion in patients with atrial fibrillation and different anticoagulant regimens.
    Maltagliati A; Galli CA; Tamborini G; Calligaris A; Doria E; Salehi R; Pepi M
    Heart; 2006 Jul; 92(7):933-8. PubMed ID: 16284221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and predictors of left atrial thrombosis in atrial fibrillation patients treated with non-vitamin K antagonist oral anticoagulants.
    Angelini F; Bocchino PP; Peyracchia M; Saglietto A; Magnano M; Patanè N; D'Ascenzo F; Giustetto C; Anselmino M; Gaita F; Toso E
    Acta Cardiol; 2023 May; 78(3):290-297. PubMed ID: 34821203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Embolic events in patients with atrial fibrillation and effective anticoagulation: value of transesophageal echocardiography to guide direct-current cardioversion. Final results of the Ludwigshafen Observational Cardioversion Study.
    Seidl K; Rameken M; Drögemüller A; Vater M; Brandt A; Schwacke H; Bergmeier C; Zahn R; Senges J
    J Am Coll Cardiol; 2002 May; 39(9):1436-42. PubMed ID: 11985904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-vitamin K antagonist oral anticoagulants in atrial fibrillation patients undergoing elective cardioversion.
    Itäinen S; Lehto M; Vasankari T; Mustonen P; Kotamäki M; Numminen A; Lahtela H; Bah A; Hartikainen J; Hekkala AM; Airaksinen JKE
    Europace; 2018 Apr; 20(4):565-568. PubMed ID: 29016758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.